Rockefeller Capital Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,886
| Closed | -$10K | – | 2710 |
|
|
2022
Q4 | $10K | Hold |
8,886
| – | – | ﹤0.01% | 3073 |
|
|
2022
Q3 | $14K | Hold |
8,886
| – | – | ﹤0.01% | 2929 |
|
|
2022
Q2 | $11K | Hold |
8,886
| – | – | ﹤0.01% | 3063 |
|
|
2022
Q1 | $14K | Sell |
8,886
-4,000
| -31% | -$6.3K | ﹤0.01% | 2885 |
|
|
2021
Q4 | $26K | Hold |
12,886
| – | – | ﹤0.01% | 2513 |
|
|
2021
Q3 | $49K | Buy |
12,886
+2,500
| +24% | +$9.51K | ﹤0.01% | 2148 |
|
|
2021
Q2 | $33K | Buy |
10,386
+8,386
| +419% | +$26.6K | ﹤0.01% | 2257 |
|
|
2021
Q1 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 2962 |
|
|
2020
Q4 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 2488 |
|
|
2020
Q3 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 2218 |
|
|
2020
Q2 | $6K | Hold |
2,000
| – | – | ﹤0.01% | 2030 |
|
|
2020
Q1 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 2012 |
|
|
2019
Q4 | $6K | Buy |
+2,000
| New | +$6K | ﹤0.01% | 1740 |
|